[{"quiz_id": "20251225T204141396Z_grok-4-0709_seed132", "question_id": "20251225T204141396Z_grok-4-0709_seed132-001", "question": "A 45-year-old man presents with progressive bilateral leg weakness, urinary incontinence, and episodic vertigo over 6 months. Examination reveals spastic paraparesis, upbeat nystagmus, and a positive Romberg sign. MRI shows T2 hyperintensities in the cerebellar peduncles and periventricular white matter. CSF analysis is normal except for elevated IgG index. What is the most likely diagnosis?", "options": ["Primary progressive multiple sclerosis", "Susac syndrome", "Behçet disease", "Neuromyelitis optica spectrum disorder", "Cerebrotendinous xanthomatosis"], "answer": "B", "answer_index": 1, "explanation": "Susac syndrome is characterized by the triad of encephalopathy, branch retinal artery occlusions, and sensorineural hearing loss, but can present with cerebellar involvement and white matter lesions mimicking multiple sclerosis. Primary progressive multiple sclerosis typically lacks the specific upbeat nystagmus and vertigo seen here, while Behçet disease often includes oral ulcers and uveitis, which are absent. Neuromyelitis optica spectrum disorder usually features optic neuritis or transverse myelitis with aquaporin-4 antibodies, not present in this case.", "generator_model": "grok-4-0709", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: K (Miskeyed). Verdict: Miskeyed; the stem supports Option A (Primary Progressive Multiple Sclerosis), but the key is B. \\n\\nThe vignette describes a classic presentation of Primary Progressive Multiple Sclerosis (PPMS): a middle-aged male with progressive spastic paraparesis (myelopathy), cerebellar signs (vertigo, upbeat nystagmus), periventricular/cerebellar MRI lesions, and an elevated IgG index (a specific hallmark of MS found in >90% of cases). Option A is the medically superior answer.\\n\\nThe keyed answer, Susac syndrome (B), is incorrect. Susac syndrome is a microangiopathy defined by the clinical triad of encephalopathy, branch retinal artery occlusions (BRAO), and sensorineural hearing loss—none of which are mentioned in the stem. Additionally, Susac MRI findings typically involve 'snowball' lesions in the corpus callosum, and CSF usually shows elevated protein rather than the elevated IgG index/oligoclonal bands seen in MS. The rationale falsely claims upbeat nystagmus excludes MS; in reality, upbeat nystagmus localizes to the brainstem or cerebellar vermis, which are common sites of demyelination in MS. The item is scientifically inaccurate as keyed.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: K (Miskeyed). Verdict: Miskeyed; the stem supports Option A (Primary Progressive Multiple Sclerosis), but the key is B. \n\nThe vignette describes a classic presentation of Primary Progressive Multiple Sclerosis (PPMS): a middle-aged male with progressive spastic paraparesis (myelopathy), cerebellar signs (vertigo, upbeat nystagmus), periventricular/cerebellar MRI lesions, and an elevated IgG index (a specific hallmark of MS found in >90% of cases). Option A is the medically superior answer.\n\nThe keyed answer, Susac syndrome (B), is incorrect. Susac syndrome is a microangiopathy defined by the clinical triad of encephalopathy, branch retinal artery occlusions (BRAO), and sensorineural hearing loss—none of which are mentioned in the stem. Additionally, Susac MRI findings typically involve 'snowball' lesions in the corpus callosum, and CSF usually shows elevated protein rather than the elevated IgG index/oligoclonal bands seen in MS. The rationale falsely claims upbeat nystagmus excludes MS; in reality, upbeat nystagmus localizes to the brainstem or cerebellar vermis, which are common sites of demyelination in MS. The item is scientifically inaccurate as keyed.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251225T204141396Z_grok-4-0709_seed132", "question_id": "20251225T204141396Z_grok-4-0709_seed132-002", "question": "A 32-year-old woman with a history of atopic dermatitis develops widespread pruritic vesicles and bullae after starting a new biologic therapy. Biopsy shows subepidermal clefting with eosinophils and flame figures. Direct immunofluorescence is negative. What is the most appropriate next step in management?", "options": ["Switch to dupilumab", "Initiate dapsone therapy", "Administer rituximab", "Prescribe high-dose systemic corticosteroids", "Perform patch testing for contact allergens"], "answer": "B", "answer_index": 1, "explanation": "This presentation suggests bullous pemphigoid-like eruption induced by biologic therapy, but the flame figures and eosinophilic spongiosis point to eosinophilic cellulitis (Wells syndrome), which responds well to dapsone. Switching to dupilumab might exacerbate atopic conditions without addressing the eosinophilic component, while rituximab is reserved for refractory autoimmune bullous diseases. Systemic corticosteroids could provide temporary relief but are not first-line for this entity.", "generator_model": "grok-4-0709", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Dermatology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a classic presentation of Wells syndrome (eosinophilic cellulitis), indicated by the hallmark histologic finding of 'flame figures' (collagen fibers coated with eosinophil granule proteins), eosinophilic infiltration, and negative direct immunofluorescence (ruling out autoimmune bullous diseases like bullous pemphigoid). The standard, first-line treatment for acute, widespread Wells syndrome is systemic corticosteroids (Option D). While dapsone (Option B) is a valid second-line or steroid-sparing agent for refractory or chronic cases, it is not the initial treatment of choice for an acute, widespread eruption. The author's rationale incorrectly asserts that systemic corticosteroids are not first-line, contradicting major dermatology textbooks and guidelines. Because the medically correct best answer (D) is listed but not keyed, and the keyed answer (B) is inferior, the item is miskeyed.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a classic presentation of Wells syndrome (eosinophilic cellulitis), indicated by the hallmark histologic finding of 'flame figures' (collagen fibers coated with eosinophil granule proteins), eosinophilic infiltration, and negative direct immunofluorescence (ruling out autoimmune bullous diseases like bullous pemphigoid). The standard, first-line treatment for acute, widespread Wells syndrome is systemic corticosteroids (Option D). While dapsone (Option B) is a valid second-line or steroid-sparing agent for refractory or chronic cases, it is not the initial treatment of choice for an acute, widespread eruption. The author's rationale incorrectly asserts that systemic corticosteroids are not first-line, contradicting major dermatology textbooks and guidelines. Because the medically correct best answer (D) is listed but not keyed, and the keyed answer (B) is inferior, the item is miskeyed.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251225T204141396Z_grok-4-0709_seed132", "question_id": "20251225T204141396Z_grok-4-0709_seed132-003", "question": "A 58-year-old man with incomplete tetraplegia from a C5 spinal cord injury undergoes functional electrical stimulation therapy. After 3 months, he develops shoulder pain and limited abduction. Imaging reveals heterotopic ossification around the glenohumeral joint. What is the most effective intervention to preserve joint mobility?", "options": ["Bisphosphonate therapy", "Low-dose radiation", "Surgical excision", "Indomethacin prophylaxis", "Passive range-of-motion exercises"], "answer": "B", "answer_index": 1, "explanation": "Low-dose radiation therapy is highly effective in preventing maturation of heterotopic ossification in spinal cord injury patients, preserving joint function without systemic side effects. Bisphosphonates like etidronate can inhibit mineralization but are less targeted and may cause gastrointestinal issues. Surgical excision is considered only after ossification matures and if function is severely impaired, not as a primary intervention.", "generator_model": "grok-4-0709", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Physical Medicine and Rehabilitation", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: Miskeyed (K). The vignette describes a patient with active, established heterotopic ossification (HO) (confirmed by imaging) causing pain and limited motion. The standard medical management to arrest the progression of active HO in spinal cord injury is bisphosphonate therapy (Option A) or NSAIDs. Low-dose radiation (Option B) is the standard of care for *prophylaxis* (e.g., immediately post-injury or post-surgical excision) to prevent HO formation or recurrence. It is not the standard first-line intervention for *existing* active HO in SCI patients to preserve mobility, whereas bisphosphonates (like etidronate) are FDA-approved and guideline-supported for this specific indication. Option D (Indomethacin) is also a treatment, but labeled 'prophylaxis' which is semantically incorrect for established disease. Surgical excision (Option C) is contraindicated until maturation. Thus, Option A is the correct best answer based on standard PM&R and SCI guidelines. The provided key (B) conflates prophylaxis with active treatment.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: Miskeyed (K). The vignette describes a patient with active, established heterotopic ossification (HO) (confirmed by imaging) causing pain and limited motion. The standard medical management to arrest the progression of active HO in spinal cord injury is bisphosphonate therapy (Option A) or NSAIDs. Low-dose radiation (Option B) is the standard of care for *prophylaxis* (e.g., immediately post-injury or post-surgical excision) to prevent HO formation or recurrence. It is not the standard first-line intervention for *existing* active HO in SCI patients to preserve mobility, whereas bisphosphonates (like etidronate) are FDA-approved and guideline-supported for this specific indication. Option D (Indomethacin) is also a treatment, but labeled 'prophylaxis' which is semantically incorrect for established disease. Surgical excision (Option C) is contraindicated until maturation. Thus, Option A is the correct best answer based on standard PM&R and SCI guidelines. The provided key (B) conflates prophylaxis with active treatment.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251225T204141396Z_grok-4-0709_seed132", "question_id": "20251225T204141396Z_grok-4-0709_seed132-004", "question": "A 67-year-old woman with a history of migraine presents with acute onset of hemianopia, ataxia, and confusion. CT angiography shows occlusion of the posterior inferior cerebellar artery with extension into the basilar artery. Despite thrombolysis, she deteriorates with locked-in syndrome. What rare complication is most likely responsible for this progression?", "options": ["Reperfusion injury", "Basilar artery dissection", "Paradoxical embolism", "Top-of-the-basilar syndrome", "Intracranial atherosclerotic disease"], "answer": "C", "answer_index": 2, "explanation": "Paradoxical embolism through a patent foramen ovale can cause extension of infarction in vertebrobasilar territory, leading to locked-in syndrome despite initial thrombolysis. Reperfusion injury typically manifests as hemorrhage, not progression of ischemia, while basilar artery dissection would show characteristic imaging findings not described. Top-of-the-basilar syndrome involves thalamic and midbrain infarction but lacks the cerebellar involvement here.", "generator_model": "grok-4-0709", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item is logically invalid and medically confused. The question asks for a \\\"rare complication\\\" responsible for clinical \\\"progression\\\" after thrombolysis. The keyed answer, \\\"Paradoxical embolism,\\\" is an *etiology* of stroke (suggested by the \\\"migraine\\\" clue), not a complication of the stroke or treatment that explains subsequent deterioration. Progression to locked-in syndrome in a patient with an existing basilar occlusion is typically due to clot propagation, failure of recanalization, or edema, not the original embolic mechanism acting again as a \\\"complication.\\\" Additionally, paradoxical embolism is not a \\\"complication\\\" of the progression; it is the primary cause. Option B (Dissection) or A (Reperfusion injury) are more plausible mechanisms for deterioration/progression, but the key forces an etiology-based answer that does not fit the question stem's constraints. The item conflates \\\"cause of stroke\\\" with \\\"cause of deterioration,\\\" making the keyed answer unresponsive to the specific question asked.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"N\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item is logically invalid and medically confused. The question asks for a \"rare complication\" responsible for clinical \"progression\" after thrombolysis. The keyed answer, \"Paradoxical embolism,\" is an *etiology* of stroke (suggested by the \"migraine\" clue), not a complication of the stroke or treatment that explains subsequent deterioration. Progression to locked-in syndrome in a patient with an existing basilar occlusion is typically due to clot propagation, failure of recanalization, or edema, not the original embolic mechanism acting again as a \"complication.\" Additionally, paradoxical embolism is not a \"complication\" of the progression; it is the primary cause. Option B (Dissection) or A (Reperfusion injury) are more plausible mechanisms for deterioration/progression, but the key forces an etiology-based answer that does not fit the question stem's constraints. The item conflates \"cause of stroke\" with \"cause of deterioration,\" making the keyed answer unresponsive to the specific question asked.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "N", "verdict": "FAIL", "fail_reason": "N"}, "judge_verdict": "FAIL", "judge_fail_reason": "N", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251225T204141396Z_grok-4-0709_seed132", "question_id": "20251225T204141396Z_grok-4-0709_seed132-005", "question": "A 28-year-old man presents with erythematous plaques on the trunk and extremities that worsen with sun exposure. Biopsy reveals interface dermatitis with vacuolar degeneration and apoptotic keratinocytes. Serology shows positive anti-Ro/SSA antibodies. Despite hydroxychloroquine, lesions persist. What is the most appropriate adjunctive therapy?", "options": ["Thalidomide", "Mycophenolate mofetil", "Intravenous immunoglobulin", "Lenalidomide", "Apremilast"], "answer": "A", "answer_index": 0, "explanation": "This is subacute cutaneous lupus erythematosus, and thalidomide is effective for refractory cases with photosensitivity and anti-Ro positivity due to its anti-angiogenic and immunomodulatory effects. Mycophenolate mofetil is more suited for systemic lupus but less effective for cutaneous-limited disease. Intravenous immunoglobulin is reserved for severe systemic involvement, not primarily cutaneous manifestations.", "generator_model": "grok-4-0709", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Dermatology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a patient with Subacute Cutaneous Lupus Erythematosus (SCLE) refractory to hydroxychloroquine. The keyed answer is Thalidomide (A). However, current clinical guidelines (e.g., American Academy of Dermatology) typically recommend a stepwise approach where methotrexate or mycophenolate mofetil (Option B) are utilized *before* thalidomide. While thalidomide is historically the most potent agent for cutaneous lupus, its use is strictly limited by severe toxicity (peripheral neuropathy, thromboembolism) and REMS protocols. Mycophenolate mofetil (MMF) is a standard, safer second-line systemic agent for cutaneous LE. Therefore, Option B is arguably more 'appropriate' than Option A as the next step due to its superior safety profile. At a minimum, Option B is equally defensible to Option A, creating a 'Multiple Correct Answers' issue. The explanation incorrectly minimizes MMF's role, which is widely accepted for refractory cutaneous disease before escalating to thalidomide. To fix, Option B should be replaced with a non-therapeutic distractor or the stem should specify 'refractory to antimalarials and immunosuppressants.'\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a patient with Subacute Cutaneous Lupus Erythematosus (SCLE) refractory to hydroxychloroquine. The keyed answer is Thalidomide (A). However, current clinical guidelines (e.g., American Academy of Dermatology) typically recommend a stepwise approach where methotrexate or mycophenolate mofetil (Option B) are utilized *before* thalidomide. While thalidomide is historically the most potent agent for cutaneous lupus, its use is strictly limited by severe toxicity (peripheral neuropathy, thromboembolism) and REMS protocols. Mycophenolate mofetil (MMF) is a standard, safer second-line systemic agent for cutaneous LE. Therefore, Option B is arguably more 'appropriate' than Option A as the next step due to its superior safety profile. At a minimum, Option B is equally defensible to Option A, creating a 'Multiple Correct Answers' issue. The explanation incorrectly minimizes MMF's role, which is widely accepted for refractory cutaneous disease before escalating to thalidomide. To fix, Option B should be replaced with a non-therapeutic distractor or the stem should specify 'refractory to antimalarials and immunosuppressants.'", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251225T204141396Z_grok-4-0709_seed132", "question_id": "20251225T204141396Z_grok-4-0709_seed132-006", "question": "A 42-year-old woman with rheumatoid arthritis and secondary fibromyalgia undergoes multidisciplinary pain management. She reports persistent widespread pain despite optimized pharmacotherapy. Quantitative sensory testing shows central sensitization. What advanced rehabilitation technique is most likely to provide long-term benefit?", "options": ["Graded motor imagery", "Transcutaneous electrical nerve stimulation", "Aquatic therapy", "Cognitive behavioral therapy alone", "Spinal cord stimulation"], "answer": "A", "answer_index": 0, "explanation": "Graded motor imagery effectively addresses central sensitization in fibromyalgia by reprogramming cortical representations, leading to sustained pain reduction in rheumatoid arthritis overlap. Transcutaneous electrical nerve stimulation provides short-term relief but does not target central mechanisms. Spinal cord stimulation is invasive and indicated for neuropathic pain, not widespread fibromyalgia pain.", "generator_model": "grok-4-0709", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Physical Medicine and Rehabilitation", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a patient with fibromyalgia and central sensitization, asking for the rehabilitation technique most likely to provide long-term benefit. The keyed answer, Graded Motor Imagery (GMI), is a well-established treatment for Complex Regional Pain Syndrome (CRPS) and phantom limb pain, where cortical remapping is the primary goal. However, for fibromyalgia, GMI is considered experimental with limited evidence compared to established standards. Option C (Aquatic therapy) has robust Level 1 evidence and is strongly recommended by major international guidelines (EULAR, ACR) as a first-line rehabilitation modality with proven long-term benefits for fibromyalgia. While the stem includes the clue 'central sensitization' (which GMI targets mechanistically), prioritizing a niche/theoretical treatment over a gold-standard, guideline-supported intervention constitutes a medical error regarding 'most likely benefit.' A knowledgeable candidate would select Option C. The term 'advanced' is too vague to exclude aquatic therapy, making the item miskeyed based on current medical evidence.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a patient with fibromyalgia and central sensitization, asking for the rehabilitation technique most likely to provide long-term benefit. The keyed answer, Graded Motor Imagery (GMI), is a well-established treatment for Complex Regional Pain Syndrome (CRPS) and phantom limb pain, where cortical remapping is the primary goal. However, for fibromyalgia, GMI is considered experimental with limited evidence compared to established standards. Option C (Aquatic therapy) has robust Level 1 evidence and is strongly recommended by major international guidelines (EULAR, ACR) as a first-line rehabilitation modality with proven long-term benefits for fibromyalgia. While the stem includes the clue 'central sensitization' (which GMI targets mechanistically), prioritizing a niche/theoretical treatment over a gold-standard, guideline-supported intervention constitutes a medical error regarding 'most likely benefit.' A knowledgeable candidate would select Option C. The term 'advanced' is too vague to exclude aquatic therapy, making the item miskeyed based on current medical evidence.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}]